A recent study, Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women, published in the Journal of the American Medical Association (JAMA), showed that a single large […]

Osteoporosis Canada’s overall position statement in response to this study: This study did not specifically address the vitamin D requirements of individuals with osteoporosis, those with risk factors for osteoporotic […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

Healthcare Provider Webinar: Biologics & Biosimilars – An Overview for Healthcare Providers In the treatment of osteoporosis, biologic and biosimilar medications may be provided as part of a treatment plan. […]

Latest News Nine Drug Formularies In Canada List Evenity® For Reimbursement For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk Of Fracture April 3, 2024 Amgen Canada has […]

With 80% of Canadians suffering from a fragility fracture and not receiving appropriate treatment, Horizon Health Network identified the need for a Fracture Liaison Service (FLS) to reduce care gap individuals with osteoporosis in Fredericton and surrounding areas.

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

National E-Newsletter Sign up now to receive Osteoporosis Canada’s National Newsletter Osteoporosis Canada’s national e-communications showcase current organizational developments, updates on osteoporosis and bone health, new initiatives and more.

If you live within the city of Winnipeg, Manitoba register for a virtual cooking class where you will receive a 1-hour interactive instructive cook-along for you to learn new recipes […]